IL-2-activated NK cells in presence of l-kynurenine show impaired expression of the activating receptors NKp46 and NKG2D, lower production of IFN-γ and TNF-α, and reduced cytotoxicity against tumor cells (106). The gene discussed is NCR1; the disease is neoplasm.